Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Common Stock | Award | $16.5M | +68K | +17.01% | $243.27 | 468K | Feb 9, 2022 | Direct | |
holding | LLY | Common Stock | 63.5K | Feb 9, 2022 | By David A. Ricks SLAT | F1 | |||||
holding | LLY | Common Stock | 7.09K | Feb 9, 2022 | 401(k) |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Restricted Stock Unit | Award | $0 | +47.8K | $0.00 | 47.8K | Feb 9, 2022 | Common Stock | 47.8K | Direct | F2 |
Id | Content |
---|---|
F1 | The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |